🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance

Cancers(2023)10.3390/cancers15133390Source: DataRank Database

Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0. It has been cited 38 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access38 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 5.23)OA: goldTopics (31)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Wenzhou Wang ORCID,Marisela Sheldon,Yutong Sun ORCID,Fan Yao ORCID,Li Ma ORCID

Live enrichment

PubMed:37444501 PMC:PMC10341343 OpenAlex:https://openalex.org/W4382724131

Hubei Provincial Natural Science Foundation

Grant: 2022CFA108

Hubei Provincial Natural Science Foundation

Grant: 2022hszd028

Hubei Provincial Natural Science Foundation

Grant: 2021hszd012

Hubei Provincial Natural Science Foundation

Grant: SZYJY2023008

Hubei Provincial Natural Science Foundation

Grant: ZY2023Q037

Hubei Provincial Natural Science Foundation

Grant: R01CA166051

Hubei Provincial Natural Science Foundation

Grant: R01CA269140

Hubei Provincial Natural Science Foundation

Grant: RP190029

Hubei Provincial Natural Science Foundation

Grant: DBG-22-161-01-MM

National Institutes of Health

Grant: 5R01CA166051-03

Regulation of metastasis and epithelial-mesenchymal transition by microRNAs

National Institutes of Health

Grant: 5R01CA269140-02

Targeting the LIFR-LCN2 pathway to improve liver cancer therapy

FWCI

5.23

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2072-6694/15/13/3390/pdf?version=1688012478

publisherhttps://www.mdpi.com/2072-6694/15/13/3390/pdf?version=1688012478

publisherhttps://www.mdpi.com/2072-6694/15/13/3390/pdf

journalhttps://doi.org/10.3390/cancers15133390

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37444501

Fields of Study

Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and CancerEpigenetics and DNA Methylation03 medical and health sciences0302 clinical medicine

Keywords

Breast cancerReprogrammingMedicineCancerMetastasisDrug resistanceBioinformaticsCancer researchPharmacologyBiologyInternal medicineCellBiochemistryGeneticsmetabolic inhibitorglucose metabolismTumor MicroenvironmentWarburg EffectReverse Warburg EffectMedical Sciences610ReviewBiomedical InformaticsOncologyMedical SpecialtiesMedicine and Health Sciences

Sustainable Development Goals

SDG 0: Good health and well-being